XML 32 R24.htm IDEA: XBRL DOCUMENT v3.23.2
Organization and Business Description (Tables)
 6 Months Ended
Mar. 31, 2023
Organization and Business Description [Abstract]  
Schedule of Consolidated Financial Statements of the Companies The unaudited condensed consolidated financial statements of the Company include the following entities:
Name of Entity   Date of
Incorporation		   Place of
Incorporation		   % of
Ownership		   Principal Activities
Jin Med   January 14, 2020   Cayman Island   Parent   Investment holding
                 
Zhongjin HK   February 25, 2020   Hong Kong   100%   Investment holding
                 
Erhua Med   September 24, 2020   PRC   100%   WFOE, Investment holding
                 
Changzhou Zhongjin   January 26, 2006   PRC   VIE   Design, development, manufacturing and sales of wheelchair and other mobility products
                 
Taizhou Zhongjin   June 17, 2013   PRC   100% controlled subsidiary of the VIE   Design, development, manufacturing and sales of wheelchair and other mobility products
                 
Zhongjin Jing’ao   December 18, 2014   PRC   100% controlled subsidiary of the VIE   Design, development, manufacturing and sales of wheelchair and other mobility products

 
Schedule of Condensed Consolidated Financial Statements The following financial statement amounts and balances of the VIE and VIE’s subsidiaries were included in the accompanying unaudited condensed consolidated financial statements after elimination of intercompany transactions and balances:
   March 31,
2023		   September 30,
2022		 
Current assets  $22,301,879   $18,903,147 
Non-current assets   1,933,397    2,036,387 
Total assets  $24,235,276   $20,939,534 
Current liabilities  $7,475,978   $5,703,843 
Non-current liabilities   
-
    
-
 
Total liabilities  $7,475,978   $5,703,843 
Schedule of Revenue
   For the Six Months Ended
March 31,		 
   2023   2022 
Net revenue  $10,253,163   $9,467,621 
Net income  $1,766,347   $1,225,864 
Schedule of Cash Flow Statement
   For the Six Months Ended
March 31,		 
   2023   2022 
Net cash provided by (used in) operating activities  $2,743,493   $(51,274)
Net cash used in investing activities  $(7,073,829)  $(40,816)
Net cash provided by (used in) financing activities  $1,312,667   $(6,468)